Frontlight ResearchEarly access
TerminatedNo phase
Long COVID-19 Rehabilitation & Recovery Research Program
Key facts
- Who runs it
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Where
- Torrance, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 21 people enrolled
- Started
- 2 Feb 2022
- Ended
- 31 Dec 2023
- Type of study
- Interventional
- Treatments tested
- On Site Exercise Rehabilitation
- Record updated
- 22 September 2025
- Why it stopped
- Funding exhausted.
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Long COVID-19 Infection (Documented by PCR or patient report)
- Age >= 18 years old
- At least 12 weeks since the initial COVID Infection
- One or more of the following symptom/signs: Fatigue, Dyspnea, Exercise Intolerance, Post Exertional Malaise and/or Difficulty Breathing
- Able to perform a cardiopulmonary exercise test
Who cannot take part
- Patients who have completed a pulmonary rehabilitation program in the six weeks prior to the screening visit or patients who are currently in a pulmonary rehabilitation program
- Patients who have taken an investigational drug within one month or six half-lives (whichever is greater) prior to screening visit (Visit 1)
- Malignancy for which the patient has undergone resection, radiation therapy, or chemotherapy within the last 2 years
- Any other significant disease than COVID-19 which, in the opinion of the investigator, may i) put the patient at risk because of participation in the study, ii) influence the results of the study (e.g. Insulin or testosterone therapy, systemic corticosteroids, HIV, etc), iii) cause concern regarding the patient's ability to participate in the study
- Patients is not able to perform technically acceptable pulmonary function tests and symptom-limited cardiopulmonary cycle ergometry tests
- Patients who desaturate to SpO2 <80% on screening incremental exercise testing
- Pregnant or nursing women
- Women of childbearing potential who are not using a highly effective method of birth control. Female patients will be considered of childbearing potential unless surgically sterilized by hysterectomy or bilateral tubal ligation, or post-menopausal for at least two years
- Patients who are currently participating in another interventional study
Where in United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, United States
About the trial
What the trial wants to find out
The purpose of the study is to assess the physiologic, immunologic, and mental health effects of an exercise and pulmonary rehabilitation program on patients with Long COVID-19 (LC).
The group in the trial
- +/- PEMTreatment being tested
Patients with and without Post Exertional Malaise (PEM) will receive 10 weeks of on site low to moderate intensity exercise rehabilitation.
Treatment: On Site Exercise Rehabilitation
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Long COVID-19 Rehabilitation & Research Program
- Publications
- Record updated
- 22 September 2025